Abstract
Background: In 2011 the C9ORF72 repeat expansion was identified as the most frequent genetic mutation underlying FTD and ALS. The main aim of this study was to investigate clinical characteristics in a large C9ORF72-positive FTD family, and to compare these with the neuropathological findings. Methods: The clinical records of 12 related FTD patients were thoroughly evaluated. The five neuropathologically examined cases were revised using additional TDP-43 immuno-stainings. Four cases were screened for the C9ORF72 expansion. Results: All 12 patients fulfilled the criteria for bvFTD. Restlessness and social neglect were often among the first reported symptoms. Psychotic symptoms were reported in 8 patients. Somatic complaints were seen in 7 cases. All the neuropathologically examined cases were TDP-43 positive. Conclusions: The phenotype of this C9ORF72 hexanucleotide expansion carrier family was bvFTD. The clinical symptom profile was strikingly homogenous. Psychotic symptoms and somatic complaints were observed in most of the cases.
| Original language | English |
|---|---|
| Pages (from-to) | 276-286 |
| Number of pages | 11 |
| Journal | American Journal of Neurodegenerative Diseases |
| Volume | 2 |
| Issue number | 4 |
| State | Published - 15 Dec 2013 |
| Externally published | Yes |
Keywords
- FTD
- Genetics
- Longitudinal study
- Psychotic symptoms
- TDP-43